Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | 1 | IL-1RA | 26.0 | 50 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | IL-1RA | 26.0 | 49 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | IL-1RA | 24.0 | 53 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | IL-1RA | 25.0 | 40 | ||||
N2586 | 1 | IL-1RA | 22.5 | 60 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | IL-1RA | 23.0 | 51 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | IL-1RA | 29.0 | 45 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | IL-1RA | 25.5 | 56 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | IL-1RA | 23.0 | 39 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | IL-1RA | 29.5 | 52 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | IL-1RA | 24.5 | 66 | ||||
RA2159 | EGF | 100 | ng/mL | 1 | IL-1RA | 22.0 | 72 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 23.0 | 55 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 24.0 | 53 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 25.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 23.0 | 66 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 25.0 | 52 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 1 | IL-1RA | 25.0 | 67 | ||||
N2586 | EGF | 100 | ng/mL | 1 | IL-1RA | 24.0 | 71 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 25.0 | 68 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 24.0 | 59 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 20.0 | 45 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 22.0 | 71 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IL-1RA | 18.5 | 42 | |
N2586 | JNK-IN-11 | 0.3 | uM | 1 | IL-1RA | 23.0 | 50 |